Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)' - S&P Global Ratings’ Credit Research

Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)'

Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)' - S&P Global Ratings’ Credit Research
Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)'
Published Jan 27, 2023
3 pages (1383 words) — Published Jan 27, 2023
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

ENGLEWOOD (S&P Global Ratings) Jan. 27, 2023--S&P Global Ratings today said it assigned 'BBB+ (sf)' and 'BB+ (sf)' ratings to the class A and B notes, respectively, issued by Vitality Re XIV Ltd. The notes will cover claims payments of Health Re Inc.--and, ultimately, Aetna Life Insurance Co. (ALIC; A-/Stable/--)--related to the covered insurance business to the extent the medical benefit ratio (MBR) exceeds 106% for the class A notes and 100% for the class B notes. The MBR is calculated on an annual aggregate basis. We base our ratings on the lowest of the following: The MBR risk factor on the ceded risk ('bbb+' for the class A notes and 'bb+' for the class B notes), The rating on

  
Brief Excerpt:

...January 27, 2023 ENGLEWOOD (S&P Global Ratings) Jan. 27, 2023--S&P Global Ratings today said it assigned '###+ (sf)' and '##+ (sf)' ratings to the class A and B notes, respectively, issued by Vitality Re XIV Ltd. The notes will cover claims payments of Health Re Inc.--and, ultimately, Aetna Life Insurance Co. (ALIC; A-/Stable/--)--related to the covered insurance business to the extent the medical benefit ratio (MBR) exceeds 106% for the class A notes and 100% for the class B notes. The MBR is calculated on an annual aggregate basis. We base our ratings on the lowest of the following: - The MBR risk factor on the ceded risk ('###+' for the class A notes and '##+' for the class B notes), - The rating on ALIC (the underlying covered business company), or - The rating on the permitted investments ('AAAm') that will be held in the collateral account (there is a separate collateral account for each class of notes) at closing. According to the risk analysis provided by Milliman Inc., one of the...

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance, Structured Finance
Country
Region
Latin America
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)'" Jan 27, 2023. Alacra Store. Apr 19, 2024. <http://www.alacrastore.com/s-and-p-credit-research/Vitality-Re-XIV-Ltd-s-Series-2023-Class-A-And-B-Notes-Rated-BBB-sf-And-BB-sf-2942309>
  
APA:
S&P Global Ratings’ Credit Research. (). Vitality Re XIV Ltd.'s Series 2023 Class A And B Notes Rated 'BBB+ (sf)' And 'BB+ (sf)' Jan 27, 2023. New York, NY: Alacra Store. Retrieved Apr 19, 2024 from <http://www.alacrastore.com/s-and-p-credit-research/Vitality-Re-XIV-Ltd-s-Series-2023-Class-A-And-B-Notes-Rated-BBB-sf-And-BB-sf-2942309>
  
US$ 150.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.